Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hayman

Showing results (281-290 of 446) with videos related to

Pageof 45
Sort By:
Blood Advances|June 25, 2026
Clinical Course, Risk Factors, and Therapeutic Response in Multiple Myeloma with Central Nervous System InvolvementAlexander Xiao, Saurabh S Zanwar, Yi Lin, et al.
British Journal of Haematology|February 16, 2019
Substratification of patients with newly diagnosed standard-risk multiple myelomaMoritz Binder, S Vincent Rajkumar, Rhett P Ketterling, et al.
Blood Advances|April 12, 2022
Outcomes after biochemical or clinical progression in patients with multiple myelomaSarah Goldman-Mazur, Alissa Visram, Prashant Kapoor, et al.
Bone Marrow Transplantation|May 4, 2010
Low risk of symptomatic venous thromboembolic events during growth factor administration for PBSC mobilizationH V Naina, R K Pruthi, D J Inwards, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 8, 2025
Whole tissue proteomic analyses of cardiac ATTR and AL unveil mechanisms of tissue damageBrian C Netzel, M Cristine Charlesworth, Kenneth L Johnson, et al.
Leukemia & Lymphoma|July 15, 2021
Treatment and outcome of newly diagnosed multiple myeloma patients > 75 years old: a retrospective analysisAbdullah S Al Saleh, Alissa Visram, Harsh Parmar, et al.
Transplantation and Cellular Therapy|April 11, 2021
Second Stem Cell Transplantation for Relapsed Refractory Light Chain (AL) AmyloidosisEli Muchtar, Angela Dispenzieri, Shaji K Kumar, et al.
European Journal of Haematology|December 1, 2020
Use of beta blockers is associated with survival outcome of multiple myeloma patients treated with pomalidomideYi L Hwa, Martha Q Lacy, Morie A Gertz, et al.
Blood Cancer Journal|March 12, 2016
Occurrence and prognostic significance of cytogenetic evolution in patients with multiple myelomaM Binder, S V Rajkumar, R P Ketterling, et al.
Bone Marrow Transplantation|April 12, 2016
Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapyW I Gonsalves, S V Rajkumar, M A Gertz, et al.
Pageof 45

Showing results (281-290 of 446) with videos related to

Sort By:
Pageof 45
Blood Advances|June 25, 2026
Clinical Course, Risk Factors, and Therapeutic Response in Multiple Myeloma with Central Nervous System InvolvementAlexander Xiao, Saurabh S Zanwar, Yi Lin, et al.
British Journal of Haematology|February 16, 2019
Substratification of patients with newly diagnosed standard-risk multiple myelomaMoritz Binder, S Vincent Rajkumar, Rhett P Ketterling, et al.
Blood Advances|April 12, 2022
Outcomes after biochemical or clinical progression in patients with multiple myelomaSarah Goldman-Mazur, Alissa Visram, Prashant Kapoor, et al.
Bone Marrow Transplantation|May 4, 2010
Low risk of symptomatic venous thromboembolic events during growth factor administration for PBSC mobilizationH V Naina, R K Pruthi, D J Inwards, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 8, 2025
Whole tissue proteomic analyses of cardiac ATTR and AL unveil mechanisms of tissue damageBrian C Netzel, M Cristine Charlesworth, Kenneth L Johnson, et al.
Leukemia & Lymphoma|July 15, 2021
Treatment and outcome of newly diagnosed multiple myeloma patients > 75 years old: a retrospective analysisAbdullah S Al Saleh, Alissa Visram, Harsh Parmar, et al.
Transplantation and Cellular Therapy|April 11, 2021
Second Stem Cell Transplantation for Relapsed Refractory Light Chain (AL) AmyloidosisEli Muchtar, Angela Dispenzieri, Shaji K Kumar, et al.
European Journal of Haematology|December 1, 2020
Use of beta blockers is associated with survival outcome of multiple myeloma patients treated with pomalidomideYi L Hwa, Martha Q Lacy, Morie A Gertz, et al.
Blood Cancer Journal|March 12, 2016
Occurrence and prognostic significance of cytogenetic evolution in patients with multiple myelomaM Binder, S V Rajkumar, R P Ketterling, et al.
Bone Marrow Transplantation|April 12, 2016
Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapyW I Gonsalves, S V Rajkumar, M A Gertz, et al.
Pageof 45